CD79A and infection: Recent reports showed that individuals with high levels of SARS-CoV-2 spike-specific mucosal IgA and S-IgA are less likely to experience breakthrough infection with the Omicron variant, suggesting that mucosal S-IgA plays a substantial role in cross-protection against SARS-CoV-2 variants (23, 26).